BIRTH-DEFECTS FOLLOWING MATERNAL EXPOSURE TO ERGOTAMINE, BETA-BLOCKERS, AND CAFFEINE

被引：40

作者：

HUGHES, HE ^{[1
]}

GOLDSTEIN, DA ^{[1
]}

机构：

[1] HOSP SICK CHILDREN,DIV CLIN PHARMACOL,TORONTO M5G 1X8,ONTARIO,CANADA

来源：

关键词：

D O I：

10.1136/jmg.25.6.396

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

页码：396 / 399

页数：4

共 25 条

[1] BENIRSCHKE K, 1961, NY J MED, V61, P1499
[2] BRIGGS GG, 1981, DRUGS PREGNANCY LACT, P310
[3] BRIGGS GG, 1981, DRUGS PREGNANCY LACT, P312
[4] CLARK BJ, 1979, HDB EXPT PHARM, V49, P322
[5] NATURE AND ETIOLOGY OF POLAND ANOMALY
DAVID, TJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (10) : 487 - &
[6] DUKES MNG, 1984, MYLERS SIDE EFFECTS, P224
[7] THE VALUE OF CASE-REPORTS IN HUMAN TERATOLOGY
GOLDBERG, JD
GOLBUS, MS
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 154 (03) : 479 - 482
[8] JEJUNAL ATRESIA ASSOCIATED WITH CAFERGOT INGESTION DURING PREGNANCY
GRAHAM, JM
MARINPADILLA, M
HOEFNAGEL, D
[J]. CLINICAL PEDIATRICS, 1983, 22 (03) : 226 - 228
[9] GRIFFITH RW, 1979, ERGOT ALKALOIDS RELA, V49, P805
[10] HAMILTON WJ, 1972, HUMAN EMBRYOLOGY, P475